Clinical Trial Update: Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of an ImmunoVaccine Technologies cancer vaccine for advanced ovarian cancer, fallopian tube cancer, or peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• ImmunoVaccine Technologies cancer vaccine

Snippet

Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.) | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | Status: COMPLETED